Investor Group acquires Emory-Emtriva Brand Rights from Emory University


US - An investor group, comprised of Gilead Sciences Inc and Royalty Pharma, acquired the brand rights of Emtriva, from Emory University, an owner and operator of a university, for $### mil. The transaction was subject to customary closing conditions.

Deal Information

Credit & Investment Research

Market Research

News